← Back to Search

Behavioural Intervention

Acuity Software for Autism Spectrum Disorder

N/A
Waitlist Available
Research Sponsored by Experiad LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the end of the study, expected to be 18 months from the start of retroactive observation period
Awards & highlights

Summary

This trial will test improvements to a software used for collecting data during behavioral therapy sessions. The software will now have a new tool called Acuity, which is designed to help Behavior Analysts and Behavior Techn

Who is the study for?
This trial is for Behavior Analysts (BAs) and Behavior Technicians (BTs) who use the Motivity software in their practice. It's aimed at those working with individuals with Autism Spectrum Disorder to improve behavioral therapy delivery.
What is being tested?
The study is evaluating Acuity, a new clinical decision support module within the Motivity software. This Quality Improvement intervention is designed to enhance how BAs and BTs collect data and make decisions during autism behavioral therapy.
What are the potential side effects?
Since this trial involves a software feature enhancement rather than a medical treatment, traditional side effects are not applicable. However, users may experience challenges adapting to new features or technical issues.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the end of the study, expected to be 18 months from the start of retroactive observation period
This trial's timeline: 3 weeks for screening, Varies for treatment, and at the end of the study, expected to be 18 months from the start of retroactive observation period for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Frequency at which Acuity and its components are rated as suitable, fitting, or proper for achieving the goals set forth in treatment plans, as measured by surveys.
Increased adherence to prescribed dosage
Increased frequency of changes to programs and prescribed dosages, resulting in reduced Trials to Criterion and Time to Criterion.
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Acuity-EnhancedExperimental Treatment1 Intervention
Group II: Acuity-BasicExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Experiad LLCLead Sponsor
2 Previous Clinical Trials
24 Total Patients Enrolled
1 Trials studying Autism Spectrum Disorder
12 Patients Enrolled for Autism Spectrum Disorder
~68 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top